{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T01:01:03Z","timestamp":1772067663747,"version":"3.50.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"DOI":"10.1186\/1756-9966-33-24","type":"journal-article","created":{"date-parts":[[2014,3,5]],"date-time":"2014-03-05T18:02:46Z","timestamp":1394042566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["CELLFOOD\u2122 induces apoptosis in human mesothelioma and colorectal cancer cells by modulating p53, c-myc and pAkt signaling pathways"],"prefix":"10.1186","volume":"33","author":[{"given":"Barbara","family":"Nuvoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaela","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Catalani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serafina","family":"Battistelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Benedetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Canestrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossella","family":"Galati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,5]]},"reference":[{"key":"758_CR1","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1016\/j.fct.2011.06.029","volume":"49","author":"S Benedetti","year":"2011","unstructured":"Benedetti S, Catalani S, Palma F, Canestrari F: The antioxidant protection of CELLFOOD against oxidative damage in vitro. Food Chem Toxicol. 2011, 49: 2292-2298. 10.1016\/j.fct.2011.06.029.","journal-title":"Food Chem Toxicol"},{"key":"758_CR2","first-page":"316","volume":"59","author":"ME Nieddu","year":"2007","unstructured":"Nieddu ME, Menza L, Baldi F, Frediani B, Marcolongo R: Efficacy of Cellfood\u2019s therapy (deutrosulfazyme) in fibromyalgia. Reumatismo. 2007, 59: 316-321.","journal-title":"Reumatismo"},{"key":"758_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1756-9966-32-63","volume":"32","author":"S Catalani","year":"2013","unstructured":"Catalani S, Carbonaro V, Palma F, Arshakyan M, Galati R, Nuvoli B, Battistelli S, Canestrari F, Benedetti S: Metabolism modifications and apoptosis induction after CellfoodTM administration to leukemia cell lines. J Exp Clin Cancer Res. 2013, 32: 63-10.1186\/1756-9966-32-63.","journal-title":"J Exp Clin Cancer Res"},{"key":"758_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S1535-6108(02)00024-7","volume":"1","author":"DR Green","year":"2002","unstructured":"Green DR, Evan GI: A matter of life and death. Cancer Cell. 2002, 1: 19-30. 10.1016\/S1535-6108(02)00024-7.","journal-title":"Cancer Cell"},{"key":"758_CR5","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1101\/gad.13.22.2905","volume":"13","author":"SR Datta","year":"1999","unstructured":"Datta SR, Brunet A, Greenberg ME: Cellular survival: a play in three Akts. Genes Dev. 1999, 13: 2905-2927. 10.1101\/gad.13.22.2905.","journal-title":"Genes Dev"},{"key":"758_CR6","first-page":"6304","volume":"51","author":"MB Kastan","year":"1991","unstructured":"Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 1991, 51: 6304-6311.","journal-title":"Cancer Res"},{"key":"758_CR7","first-page":"121","volume":"13","author":"CP Mansur","year":"1997","unstructured":"Mansur CP: The regulation and function of the p53 tumor suppressor. Adv Dermatol. 1997, 13: 121-166.","journal-title":"Adv Dermatol"},{"key":"758_CR8","first-page":"1875","volume":"136","author":"J Sandor","year":"1995","unstructured":"Sandor J, Ambrus T, Ember I: The function of the p53 gene suppressor in carcinogenesis. Orv Hetil. 1995, 136: 1875-1883.","journal-title":"Orv Hetil"},{"key":"758_CR9","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.exger.2006.07.002","volume":"41","author":"C Schoneich","year":"2006","unstructured":"Schoneich C: Protein modification in aging: an update. Exp Gerontol. 2006, 41: 807-812. 10.1016\/j.exger.2006.07.002.","journal-title":"Exp Gerontol"},{"key":"758_CR10","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1089\/ars.2010.3644","volume":"15","author":"D Liu","year":"2011","unstructured":"Liu D, Xu Y: p53, oxidative stress, and aging. Antioxid Redox Signal. 2011, 15: 1669-1678. 10.1089\/ars.2010.3644.","journal-title":"Antioxid Redox Signal"},{"key":"758_CR11","first-page":"77","volume":"1287","author":"TM Gottlieb","year":"1996","unstructured":"Gottlieb TM, Oren M: p53 in growth control and neoplasia. Biochim Biophys Acta. 1996, 1287: 77-102.","journal-title":"Biochim Biophys Acta"},{"key":"758_CR12","doi-asserted-by":"publisher","first-page":"7942","DOI":"10.1128\/MCB.13.12.7942","volume":"13","author":"N Levy","year":"1993","unstructured":"Levy N, Yonish-Rouach E, Oren M, Kimchi A: Complementation by wild-type p53 of interleukin-6 effects on M1 cells: induction of cell cycle exit and cooperativity with c-myc suppression. Mol Cell Biol. 1993, 13: 7942-7952.","journal-title":"Mol Cell Biol"},{"key":"758_CR13","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1128\/jvi.42.3.773-779.1982","volume":"42","author":"B Vennstrom","year":"1982","unstructured":"Vennstrom B, Sheiness D, Zabielski J, Bishop JM: Isolation and characterization of c-myc, a cellular homolog of the oncogene (v-myc) of avian myelocytomatosis virus strain 29. J Virol. 1982, 42: 773-779.","journal-title":"J Virol"},{"key":"758_CR14","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/nrc904","volume":"2","author":"S Pelengaris","year":"2002","unstructured":"Pelengaris S, Khan M, Evan G: c-MYC: more than just a matter of life and death. Nat Rev Cancer. 2002, 2: 764-776. 10.1038\/nrc904.","journal-title":"Nat Rev Cancer"},{"key":"758_CR15","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.semcancer.2006.07.015","volume":"16","author":"M Vita","year":"2006","unstructured":"Vita M, Henriksson M: The Myc oncoprotein as a therapeutic target for human cancer. Semin Cancer Biol. 2006, 16: 318-330. 10.1016\/j.semcancer.2006.07.015.","journal-title":"Semin Cancer Biol"},{"key":"758_CR16","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/nrc2231","volume":"8","author":"N Meyer","year":"2008","unstructured":"Meyer N, Penn LZ: Reflecting on 25\u00a0years with MYC. Nat Rev Cancer. 2008, 8: 976-990. 10.1038\/nrc2231.","journal-title":"Nat Rev Cancer"},{"key":"758_CR17","doi-asserted-by":"crossref","first-page":"D250","DOI":"10.2741\/A239","volume":"3","author":"B Amati","year":"1998","unstructured":"Amati B, Alevizopoulos K, Vlach J: Myc and the cell cycle. Front Biosci. 1998, 3: D250-D268.","journal-title":"Front Biosci"},{"key":"758_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/MCB.19.1.1","volume":"19","author":"CV Dang","year":"1999","unstructured":"Dang CV: c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol. 1999, 19: 1-11.","journal-title":"Mol Cell Biol"},{"key":"758_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1016-8478(23)13499-6","volume":"9","author":"M Eilers","year":"1999","unstructured":"Eilers M: Control of cell proliferation by Myc family genes. Mol Cells. 1999, 9: 1-6.","journal-title":"Mol Cells"},{"key":"758_CR20","doi-asserted-by":"publisher","first-page":"982","DOI":"10.4161\/cc.8.7.7949","volume":"8","author":"P Jung","year":"2009","unstructured":"Jung P, Hermeking H: The c-MYC-AP4-p21 cascade. Cell Cycle. 2009, 8: 982-989. 10.4161\/cc.8.7.7949.","journal-title":"Cell Cycle"},{"key":"758_CR21","doi-asserted-by":"publisher","first-page":"4510","DOI":"10.1073\/pnas.081074898","volume":"98","author":"AL Gartel","year":"2001","unstructured":"Gartel AL, Ye X, Goufman E, Shianov P, Hay N, Najmabadi F, Tyner AL: Myc represses the p21(WAF1\/CIP1) promoter and interacts with Sp1\/Sp3. Proc Natl Acad Sci U S A. 2001, 98: 4510-4515. 10.1073\/pnas.081074898.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"758_CR22","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1038\/sj.onc.1201440","volume":"15","author":"D M\u00fcller","year":"1997","unstructured":"M\u00fcller D, Bouchard C, Rudolph B, Steiner P, Stuckmann I, Saffrich R, Ansorge W, Huttner W, Eilers M: Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E\/cdk2 complexes. Oncogene. 1997, 15: 2561-2576. 10.1038\/sj.onc.1201440.","journal-title":"Oncogene"},{"key":"758_CR23","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1101\/gad.13.12.1501","volume":"13","author":"CJ Sherr","year":"1999","unstructured":"Sherr CJ, Roberts JM: CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999, 13: 1501-1512. 10.1101\/gad.13.12.1501.","journal-title":"Genes Dev"},{"key":"758_CR24","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/348331a0","volume":"348","author":"A Strasser","year":"1990","unstructured":"Strasser A, Harris AW, Bath ML, Cory S: Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature. 1990, 348: 331-333. 10.1038\/348331a0.","journal-title":"Nature"},{"key":"758_CR25","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1182\/blood-2002-06-1714","volume":"101","author":"G Del Poeta","year":"2003","unstructured":"Del Poeta G, Venditti A, Del Principe MI, Maurillo L, Buccisano F, Tamburini A, Cox MC, Franchi A, Bruno A, Mazzone C, Panetta P, Suppo G, Masi M, Amadori S: Amount of spontaneous apoptosis detected by Bax\/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML). Blood. 2003, 101: 2125-2131. 10.1182\/blood-2002-06-1714.","journal-title":"Blood"},{"key":"758_CR26","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood.V86.5.1903.bloodjournal8651903","volume":"86","author":"AJ Minn","year":"1995","unstructured":"Minn AJ, Rudin CM, Boise LH, Thompson CB: Expression of bcl-xL can confer a multidrug resistance phenotype. Blood. 1995, 86: 1903-1910.","journal-title":"Blood"},{"key":"758_CR27","doi-asserted-by":"publisher","first-page":"6116","DOI":"10.1158\/1078-0432.CCR-06-0147","volume":"12","author":"T Yoshino","year":"2006","unstructured":"Yoshino T, Shiina H, Urakami S, Kikuno N, Yoneda T, Shigeno K, Igawa M: Bcl-2 expression as a predictive marker of hormone-refractory prostate cancer treated with taxane-based chemotherapy. Clin Cancer Res. 2006, 12: 6116-6124. 10.1158\/1078-0432.CCR-06-0147.","journal-title":"Clin Cancer Res"},{"key":"758_CR28","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s10059-009-0036-9","volume":"27","author":"ZX Li","year":"2009","unstructured":"Li ZX, Ouyang KQ, Jiang X, Wang D, Hu Y: Curcumin induces apoptosis and inhibits growth of human Burkitt\u2019s lymphoma in xenograft mouse model. Mol Cells. 2009, 27: 283-289. 10.1007\/s10059-009-0036-9.","journal-title":"Mol Cells"},{"key":"758_CR29","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1007\/s10637-009-9311-z","volume":"28","author":"PC Leow","year":"2010","unstructured":"Leow PC, Tian Q, Ong ZY, Yang Z, Ee PL: Antitumor activity of natural compounds, curcumin and PKF118\u2013310, as Wnt\/beta-catenin antagonists against human osteosarcoma cells. Invest New Drugs. 2010, 28: 766-782. 10.1007\/s10637-009-9311-z.","journal-title":"Invest New Drugs"},{"key":"758_CR30","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1158\/1078-0432.CCR-07-4722","volume":"14","author":"AB Kunnumakkara","year":"2008","unstructured":"Kunnumakkara AB, Diagaradjane P, Guha S, Deorukhkar A, Shentu S, Aggarwal BB, Krishnan S: Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factorkappaB- regulated gene products. Clin Cancer Res. 2008, 14: 2128-2136. 10.1158\/1078-0432.CCR-07-4722.","journal-title":"Clin Cancer Res"},{"key":"758_CR31","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1126\/science.278.5340.1073","volume":"278","author":"WK Hong","year":"1997","unstructured":"Hong WK, Sporn MB: Recent advances in chemoprevention of cancer. Science. 1997, 278: 1073-1077. 10.1126\/science.278.5340.1073.","journal-title":"Science"},{"key":"758_CR32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1749-6632.1995.tb12111.x","volume":"768","author":"LW Wattenberg","year":"1995","unstructured":"Wattenberg LW: What are the critical attributes for cancer chemopreventive agents?. Ann NY Acad Sci. 1995, 768: 73-81. 10.1111\/j.1749-6632.1995.tb12111.x.","journal-title":"Ann NY Acad Sci"},{"key":"758_CR33","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1749-6632.1995.tb12112.x","volume":"768","author":"TJ Smith","year":"1995","unstructured":"Smith TJ, Hong J-Y, Wang Z-Y, Yang CS: How can carcinogenesis be inhibited?. Ann NY Acad Sci. 1995, 768: 82-90. 10.1111\/j.1749-6632.1995.tb12112.x.","journal-title":"Ann NY Acad Sci"},{"key":"758_CR34","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1093\/jnci\/djh123","volume":"96","author":"SY Sun","year":"2004","unstructured":"Sun SY, Hail N, Lotan R: Apoptosis as a novel target for cancer chemoprevention. J Natl Cancer Inst. 2004, 96: 662-672. 10.1093\/jnci\/djh123.","journal-title":"J Natl Cancer Inst"},{"key":"758_CR35","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1756-9966-31-48","volume":"31","author":"Y Huang","year":"2012","unstructured":"Huang Y, Hu J, Zheng J, Li J, Wei T, Zheng Z, Chen Y: Down-regulation of the PI3K\/Akt signaling pathway and induction of apoptosis in CA46 Burkitt lymphoma cells by baicalin. J Exp Clin Cancer Res. 2012, 31: 48-10.1186\/1756-9966-31-48.","journal-title":"J Exp Clin Cancer Res"},{"key":"758_CR36","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1756-9966-32-30","volume":"32","author":"M Krifa","year":"2013","unstructured":"Krifa M, Alhosin M, Muller CD, Gies JP, Chekir-Ghedira L, Ghedira K, M\u00e9ly Y, Bronner C, Mousli M: Limoniastrum guyonianum aqueous gall extract induces apoptosis in human cervical cancer cells involving p16 INK4A re-expression related to UHRF1 and DNMT1 down-regulation. J Exp Clin Cancer Res. 2013, 32: 30-10.1186\/1756-9966-32-30.","journal-title":"J Exp Clin Cancer Res"},{"key":"758_CR37","doi-asserted-by":"publisher","first-page":"192464","DOI":"10.1155\/2012\/192464","volume":"2012","author":"SN Saldanha","year":"2012","unstructured":"Saldanha SN, Tollefsbol TO: The role of nutraceuticals in chemoprevention and chemotherapy and their clinical outcomes. J Oncol. 2012, 2012: 192464-","journal-title":"J Oncol"},{"key":"758_CR38","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.124.3215.269","volume":"124","author":"O Warburg","year":"1956","unstructured":"Warburg O: On respiratory impairment in cancer cells. Science. 1956, 124: 269-270.","journal-title":"Science"},{"key":"758_CR39","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0305-7372(03)00003-3","volume":"29","author":"AM Shannon","year":"2003","unstructured":"Shannon AM, Bouchier-Hayes DJ, Condron CM, Toomey D: Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies. Cancer Treat Rev. 2003, 29: 297-307. 10.1016\/S0305-7372(03)00003-3.","journal-title":"Cancer Treat Rev"},{"key":"758_CR40","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrc704","volume":"2","author":"AL Harris","year":"2002","unstructured":"Harris AL: Hypoxia\u2014a key regulatory factor in tumour growth. Nat Rev Cancer. 2002, 2: 38-47. 10.1038\/nrc704.","journal-title":"Nat Rev Cancer"},{"key":"758_CR41","first-page":"2","volume":"1","author":"EL Iorio","year":"2006","unstructured":"Iorio EL: Hypoxia, free radicals and antioxidants. The \u201cDeutrosulfazyme\u00ae\u201d paradox. Hypoxia Med J. 2006, 1: 2-32.","journal-title":"Hypoxia Med J"},{"key":"758_CR42","first-page":"287","volume":"62","author":"E Ferrero","year":"2011","unstructured":"Ferrero E, Fulgenzi A, Belloni D, Foglieni C, Ferrero ME: Cellfood\u2122 improves respiratory metabolism of endothelial cells and inhibits hypoxia-induced reactive oxygen species (ROS) generation. J Physiol Pharmacol. 2011, 62: 287-293.","journal-title":"J Physiol Pharmacol"},{"key":"758_CR43","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1378\/chest.106.5.1611","volume":"106","author":"LA Robinson","year":"1994","unstructured":"Robinson LA, Reilly RB: Localized pleural mesothelioma. The clinical spectrum. Chest. 1994, 106: 1611-1615. 10.1378\/chest.106.5.1611.","journal-title":"Chest"},{"key":"758_CR44","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1165\/ajrcmb.17.6.f141","volume":"17","author":"VC Broaddus","year":"1997","unstructured":"Broaddus VC: Asbestos, the mesothelial cell and malignancy: a matter of life or death. Am J Respir Cell Mol Biol. 1997, 17: 657-659. 10.1165\/ajrcmb.17.6.f141.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"758_CR45","volume-title":"Cancer Incidence in Five Continents","author":"World Health Organization","year":"2002","unstructured":"World Health Organization: Cancer Incidence in Five Continents. 2002, Lyon: The World Health Organization and The International Agency for Research on Cancer"},{"key":"758_CR46","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/bjc.1992.314","volume":"66","author":"T Starzynska","year":"1992","unstructured":"Starzynska T, Bromley M, Ghosh A, Stern PL: Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. Br J Cancer. 1992, 66: 558-562. 10.1038\/bjc.1992.314.","journal-title":"Br J Cancer"},{"issue":"4","key":"758_CR47","doi-asserted-by":"publisher","first-page":"e18828","DOI":"10.1371\/journal.pone.0018828","volume":"6","author":"DA Altomare","year":"2011","unstructured":"Altomare DA, Menges CW, Xu J, Pei J, Zhang L, Tadevosyan A, Neumann-Domer E, Liu Z, Carbone M, Chudoba I, Klein-Szanto AJ, Testa JR: Losses of both products of the Cdkn2a\/Arf locus contribute to asbestos-induced mesothelioma development and cooperate to accelerate tumorigenesis. PLoS ONE. 2011, 6 (4): e18828-10.1371\/journal.pone.0018828.","journal-title":"PLoS ONE"},{"key":"758_CR48","doi-asserted-by":"publisher","first-page":"5595","DOI":"10.1038\/sj.onc.1204595","volume":"20","author":"LM Boxer","year":"2001","unstructured":"Boxer LM, Dang CV: Translocations involving c-myc and c-myc function. Oncogene. 2001, 20: 5595-5610. 10.1038\/sj.onc.1204595.","journal-title":"Oncogene"},{"key":"758_CR49","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nrm1703","volume":"6","author":"S Adhikary","year":"2005","unstructured":"Adhikary S, Eilers M: Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol. 2005, 6: 635-645. 10.1038\/nrm1703.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"758_CR50","first-page":"639","volume":"10","author":"M Ramael","year":"1995","unstructured":"Ramael M, Van den Bossche J, Buysse C, Deblier I, Segers K, Van Marck E: Immunoreactivity for c-fos and c-myc protein with the monoclonal antibodies 14E10 and 6E10 in malignant mesothelioma and non-neoplastic mesothelium of the pleura. Histol Histopathol. 1995, 10: 639-643.","journal-title":"Histol Histopathol"},{"key":"758_CR51","first-page":"1049","volume":"2","author":"DR Smith","year":"1996","unstructured":"Smith DR, Goh HS: Overexpression of the c-myc proto-oncogene in colorectal carcinoma is associated with a reduced mortality that is abrogated by point mutation of the p53 tumor suppressor gene. Clin Cancer Res. 1996, 2: 1049-1053.","journal-title":"Clin Cancer Res"},{"key":"758_CR52","doi-asserted-by":"publisher","first-page":"5957","DOI":"10.1038\/onc.2010.332","volume":"29","author":"GM Marshall","year":"2010","unstructured":"Marshall GM, Gherardi S, Xu N, Neiron Z, Trahair T, Scarlett CJ, Chang DK, Liu PY, Jankowski K, Iraci N, Haber M, Norris MD, Keating J, Sekyere E, Jonquieres G, Stossi F, Katzenellenbogen BS, Biankin AV, Perini G, Liu T: Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects. Oncogene. 2010, 29: 5957-5968. 10.1038\/onc.2010.332.","journal-title":"Oncogene"},{"key":"758_CR53","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/318533a0","volume":"318","author":"JM Adams","year":"1985","unstructured":"Adams JM, Harris AW, Pinkert CA, Corcoran LM, Alexander WS, Cory S, Palmiter RD, Brinster RL: The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature. 1985, 318: 533-538. 10.1038\/318533a0.","journal-title":"Nature"},{"key":"758_CR54","first-page":"21","volume":"5","author":"SD Morgenbesser","year":"1994","unstructured":"Morgenbesser SD, DePinho RA: Use of transgenic mice to study myc family gene function in normal mammalian development and in cancer. Semin Cancer Biol. 1994, 5: 21-36.","journal-title":"Semin Cancer Biol"},{"key":"758_CR55","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0014-5793(01)02118-4","volume":"490","author":"S Nasi","year":"2001","unstructured":"Nasi S, Ciarapica R, Jucker R, Rosati J, Soucek L: Making decisions through Myc. FEBS Lett. 2001, 490: 153-162. 10.1016\/S0014-5793(01)02118-4.","journal-title":"FEBS Lett"},{"key":"758_CR56","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/j.1349-7006.2006.00294.x","volume":"97","author":"N Oka","year":"2006","unstructured":"Oka N, Tanimoto S, Taue R, Nakatsuji H, Kishimoto T, Izaki H, Fukumori T, Takahashi M, Nishitani M, Kanayama HO: Role of phosphatidylinositol-3 kinase\/Akt pathway in bladder cancer cell apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand. Cancer Sci. 2006, 97: 1093-1098. 10.1111\/j.1349-7006.2006.00294.x.","journal-title":"Cancer Sci"},{"key":"758_CR57","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/ijc.24374","volume":"125","author":"A Dieterle","year":"2009","unstructured":"Dieterle A, Orth R, Daubrawa M, Grotemeier A, Alers S, Ullrich S, Lammers R, Wesselborg S, Stork B: The Akt inhibitor triciribine sensitizes prostate carcinoma cells to TRAIL-induced apoptosis. Int J Cancer. 2009, 125: 932-941. 10.1002\/ijc.24374.","journal-title":"Int J Cancer"},{"key":"758_CR58","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/ijc.21170","volume":"117","author":"E Oki","year":"2005","unstructured":"Oki E, Baba H, Tokunaga E, Nakamura T, Ueda N, Futatsugi M, Mashino K, Yamamoto M, Ikebe M, Kakeji Y, Maehara Y: Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer. Int J Cancer. 2005, 117: 376-380. 10.1002\/ijc.21170.","journal-title":"Int J Cancer"},{"key":"758_CR59","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.canlet.2008.12.023","volume":"278","author":"K Kai","year":"2009","unstructured":"Kai K, D'Costa S, Sills RC, Kim J: Inhibition of the insulin-like growth factor 1 receptor pathway enhances the antitumor effect of cisplatin in human malignant mesothelioma cell lines. Cancer Lett. 2009, 278: 49-55. 10.1016\/j.canlet.2008.12.023.","journal-title":"Cancer Lett"},{"key":"758_CR60","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.ejcts.2007.09.045","volume":"33","author":"I Opitz","year":"2008","unstructured":"Opitz I, Soltermann A, Abaecherli M, Hinterberger M, Probst-Hensch N, Stahel R, Moch H, Weder W: PTEN expression is a strong predictor of survival in mesothelioma patients. Eur J Cardiothorac Surg. 2008, 33: 502-506. 10.1016\/j.ejcts.2007.09.045.","journal-title":"Eur J Cardiothorac Surg"},{"key":"758_CR61","doi-asserted-by":"publisher","first-page":"10761","DOI":"10.1074\/jbc.275.15.10761","volume":"275","author":"S Pugazhenthi","year":"2000","unstructured":"Pugazhenthi S, Nesterova A, Sable C, Heidenreich KA, Boxer LM, Heasley LE, Reusch JE: Akt\/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. J Biol Chem. 2000, 275: 10761-10766. 10.1074\/jbc.275.15.10761.","journal-title":"J Biol Chem"},{"key":"758_CR62","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.4161\/cbt.209","volume":"2","author":"MK Manion","year":"2003","unstructured":"Manion MK, Hockenbery DM: Targeting BCL-2- related proteins in cancer therapy. Cancer Biol Ther. 2003, 2: S105-S114.","journal-title":"Cancer Biol Ther"},{"key":"758_CR63","doi-asserted-by":"publisher","first-page":"4807","DOI":"10.1073\/pnas.0831079100","volume":"100","author":"L Li","year":"2003","unstructured":"Li L, Haynes P, Bender JR: Plasma membrane localization and function of the estrogen receptor \u03b1 variant (ER46) in human endothelial cells. Proc Natl Acad Sci U S A. 2003, 100: 4807-4812. 10.1073\/pnas.0831079100.","journal-title":"Proc Natl Acad Sci U S A"}],"updated-by":[{"DOI":"10.1186\/s13046-022-02498-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000}}],"container-title":["Journal of Experimental & Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-9966-33-24.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T20:32:17Z","timestamp":1716582737000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/1756-9966-33-24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,5]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,12]]}},"alternative-id":["758"],"URL":"https:\/\/doi.org\/10.1186\/1756-9966-33-24","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,5]]},"assertion":[{"value":"14 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13046-022-02498-9","URL":"https:\/\/doi.org\/10.1186\/s13046-022-02498-9","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"24"}}